Recent news releases
-
Nov 21, 2023 Apotex Corp. Launches Teriparatide Injectable for Osteoporosis Treatment in the United States
-
Sep 5, 2023 Apotex Corp. Launches Brimonidine Tartrate Ophthalmic Solution, 0.1% in the United States
-
Apr 26, 2023 Apotex Corp. Launches Bendamustine Hydrochloride Injection in the United States
-
Apr 19, 2023 Apotex Receives FDA’s Drug Shortage Assistance Award
-
Mar 1, 2023 Apotex Corp. Issues Voluntary Nationwide Recall of Brimonidine Tartrate Ophthalmic Solution, 0.15% due to cracks that have developed in some of the units caps of the bottles
-
Apr 12, 2022 Apotex Corp. Launches Generic of Abraxane® in the United States
-
Jan 19, 2022 Apotex Corp. Launches First-to-Market Authorized Generic Version of Combigan® Ophthalmic Solution in the United States
-
Dec 7, 2021 Apotex Corp. Announces Approval and Launch of Atropine Sulfate Ophthalmic Solution USP, 1% in the United States
-
Oct 7, 2021 Product Donation Supports Clinical Study to Evaluate FDA-Approved Medications for Mild-to-Moderate COVID-19 in Outpatients
-
Mar 31, 2021 Apotex Corp. Issues Voluntary Nationwide Recall of Guanfacine Extended-Release Tablets 2mg due to trace amounts of Quetiapine Fumarate